Universität des Saarlandes

• Andreas Keller

  Lead investigator

Sources: openalex.org

• NCT07026474

  Phase 3, Recruiting, 214 people, 18 Jun 2025

• NCT03366272

  Phase 2/3, Completed, 348 people, 8 Dec 2017

• NCT02077634

  Phase 2, Completed, 68 people, 4 Mar 2014

• NCT01047254

  Collaborator, Phase 3, Completed, 110 people, 12 Jan 2010

• NCT00726700

  Phase 2, Completed, 109 people, 1 Aug 2008

• European Commission

  HORIZON-RIA, Smart Implants for Life Enrichment, 101136376, €554.1k, 2025–2029, 6 Dec 2024

• European Commission

  HORIZON-JU-RIA, A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy, 101132901, €999.8k, 2024–2030, 27 Nov 2023

• European Commission

  HORIZON-JU-RIA, GRIP on MASH: Global Research Initiative for Patient Screening on MASH, 101132946, €640k, 2023–2027, 27 Nov 2023

• Volkswagen Foundation

  Experiment! Auf der Suche nach gewagten Forschungsideen, Non-coding RNAs as the fountain of youth, 0064739, €118.3k, 2019–2020, 1 May 2019

• Bundesministerium für Forschung, Technologie und Raumfahrt

  Mensch-Technik-Interaktion für den demografischen Wandel (abgeschlossen), KMU-innovativ - Verbundprojekt: Prävention degenerativer Demenz durch mentale, interaktive, individualisierte Stimulation - Prodemiis -, Teilvorhaben: Evaluation Computer-basierter kognitiver Interventionen bei Patienten mit Alzheimer Krankheit, 16SV7934, €309.3k, 2018–2022, 1 Apr 2018

Sources: cordis.europa.eu, openalex.org

• Trimethylamine N-oxide and major adverse cardiac and cerebrovascular events: results of umbrella review and meta-analysis

  23 Sept 2026

Sources: api.crossref.org